54: Immune trajectories in COVID-19 among patients with end-stage kidney disease episode artwork

EPISODE · Jun 24, 2025 · 18 MIN

54: Immune trajectories in COVID-19 among patients with end-stage kidney disease

from Base by Base · host Gustavo Barra

Stephenson E et al., Cell Genomics - Longitudinal single-cell multi-omics profiling of PBMCs from 61 end-stage kidney disease (ESKD) patients with COVID-19 (580,040 cells) reveals distinct temporal immune trajectories in severe versus mild disease, emergence of a dexamethasone-associated monocyte population, and expanding T cell clones enriched for SARS-CoV-2 specificity. Key terms: COVID-19, end-stage kidney disease, single-cell multi-omics, T cell receptors, glucocorticoids. Study Highlights:Longitudinal single-cell CITE-seq and paired TCR/BCR sequencing of PBMCs from ESKD patients show divergent temporal gene-expression trajectories in severe/critical versus mild/moderate COVID-19. An early and stronger interferon response is seen in severe disease with a steeper decline over time, and HLA class II expression falls over time in severe cases. The fastest-expanding T cell clones are enriched for known SARS-CoV-2-specific TCRα sequences and form public motifs with inferred MHC class II restriction. Glucocorticoid treatment (dexamethasone) is associated with the rapid emergence of a distinct CD163-high, dexamethasone-related monocyte population. Conclusion:This multi-omics longitudinal study delineates time-dependent immune differences between mild and severe COVID-19 in a high-risk ESKD population, identifies steroid-associated monocytes, and documents shared SARS-CoV-2-directed T cell clonotypes; findings are observational and do not prove causality. Music:Enjoy the music based on this article at the end of the episode. Article title:Temporal multi-omics analysis of COVID-19 in end-stage kidney disease First author:Stephenson E Journal:Cell Genomics DOI:10.1016/j.xgen.2025.100918 Reference:Stephenson E, Macdonald-Dunlop E, Dratva LM, et al. Temporal multi-omics analysis of COVID-19 in end-stage kidney disease. Cell Genomics. 2025;5:100918. doi:10.1016/j.xgen.2025.100918 License:This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/ Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00 More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/base-by-base-54-corrupted-pdf QC:This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-06-24. QC Scope:- article metadata and core scientific claims from the narration- excludes analogies, intro/outro, and music- transcript coverage: Audited transcript sections describing time-resolved multi-omics methodology, interferon dynamics, TNF expression vs protein uncoupling, dexamethasone-induced monocytes, expanding SARS-CoV-2–specific T cell clones and public TCR motifs, baseline TGF-β signaling in ESKD, HLA class II changes with severity, and Mendelian- transcript topics: Time-resolved multi-omics methodology (CITE-seq, VDJ, Olink); Interferon response dynamics in COVID-19; TNF gene expression vs TNF-α protein uncoupling; Dexamethasone-associated monocytes (dex. monos); Public SARS-CoV-2–specific T cell clones and TCR motifs; Baseline TGF-β signaling across immune cells in ESKD QC Summary:- factual score: 10/10- metadata score: 10/10- supported core claims: 7- claims flagged for review: 0- metadata checks passed: 4- metadata issues found: 0 Met...

Episode metadata supplied by the publisher feed · Published Jun 24, 2025

Embed this episode

NOW PLAYING

54: Immune trajectories in COVID-19 among patients with end-stage kidney disease

0:00 18:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Base by Base?

This episode is 18 minutes long.

When was this Base by Base episode published?

This episode was published on June 24, 2025.

Can I download this Base by Base episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!